相似文献
1
Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline.
World J Gastroenterol. 2007 Jun 14;13(22):3033-42. doi: 10.3748/wjg.v13.i22.3033.
2
Plasma citrulline concentration: a surrogate end point for radiation-induced mucosal atrophy of the small bowel. A feasibility study in 23 patients.
Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):275-85. doi: 10.1016/j.ijrobp.2004.02.052.
3
Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage.
Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1067-74. doi: 10.1016/s0360-3016(03)00781-8.
4
Citrulline as a Biomarker in the Murine Total-Body Irradiation Model: Correlation of Circulating and Tissue Citrulline to Small Intestine Epithelial Histopathology.
Health Phys. 2015 Nov;109(5):452-65. doi: 10.1097/HP.0000000000000346.
5
Plasma citrulline level as a biomarker for cancer therapy-induced small bowel mucosal damage.
Acta Biochim Pol. 2014;61(4):615-31. Epub 2014 Dec 4.
6
Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.
Cancer. 2005 Jan 1;103(1):191-9. doi: 10.1002/cncr.20733.
7
Effects of Thymoquinone on radiation enteritis in mice.
Sci Rep. 2018 Oct 11;8(1):15122. doi: 10.1038/s41598-018-33214-3.
8
Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.
Clin Nutr. 2008 Jun;27(3):328-39. doi: 10.1016/j.clnu.2008.02.005. Epub 2008 Apr 28.
9
[Plasma citrulline concentration--a reliable noninvasive marker of functional enterocyte mass].
Cas Lek Cesk. 2010;149(4):160-2.
10
Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population.
Clin Nutr. 2010 Dec;29(6):795-800. doi: 10.1016/j.clnu.2010.04.008. Epub 2010 Jun 19.
引用本文的文献
1
Serum sSelectin-L is an early specific indicator of radiation injury.
Heliyon. 2024 May 8;10(10):e30527. doi: 10.1016/j.heliyon.2024.e30527. eCollection 2024 May 30.
2
Exploring the Potential of Exosomes as Biomarkers in Tuberculosis and Other Diseases.
Int J Mol Sci. 2024 Mar 1;25(5):2885. doi: 10.3390/ijms25052885.
3
A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment.
Bioact Mater. 2023 Oct 11;32:206-221. doi: 10.1016/j.bioactmat.2023.09.014. eCollection 2024 Feb.
4
Morphological Assessment and Biomarkers of Low-Grade, Chronic Intestinal Inflammation in Production Animals.
Animals (Basel). 2022 Nov 4;12(21):3036. doi: 10.3390/ani12213036.
5
The Role of Amino Acids in Tuberculosis Infection: A Literature Review.
Metabolites. 2022 Sep 30;12(10):933. doi: 10.3390/metabo12100933.
6
Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model.
Antioxidants (Basel). 2022 Sep 25;11(10):1895. doi: 10.3390/antiox11101895.
7
Differences in the Establishment of Gut Microbiota and Metabolome Characteristics Between Balb/c and C57BL/6J Mice After Proton Irradiation.
Front Microbiol. 2022 May 6;13:874702. doi: 10.3389/fmicb.2022.874702. eCollection 2022.
8
Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways.
Radiat Res. 2022 May 1;197(5):554-558. doi: 10.1667/RADE-21-00213.1.
9
Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways.
Radiat Res. 2022 May 1;197(5):514-532. doi: 10.1667/RADE-21-00157.1.
10
Citrulline, Biomarker of Enterocyte Functional Mass and Dietary Supplement. Metabolism, Transport, and Current Evidence for Clinical Use.
Nutrients. 2021 Aug 15;13(8):2794. doi: 10.3390/nu13082794.
本文引用的文献
1
Serum and urine nitrite and citrulline levels among patients with systemic lupus erythematosus: a possible addition to activity parameters?
J Clin Rheumatol. 2001 Feb;7(1):10-5; discussion 15. doi: 10.1097/00124743-200102000-00003.
2
Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction.
Curr Surg. 2006 Sep-Oct;63(5):322-5. doi: 10.1016/j.cursur.2006.05.006.
3
The value of plasma citrulline to predict mucosal injury in intestinal allografts.
Am J Transplant. 2006 Nov;6(11):2786-90. doi: 10.1111/j.1600-6143.2006.01513.x. Epub 2006 Sep 4.
4
An association of lower serum citrulline levels within 30 days of acute rejection in patients following small intestine transplantation.
Transplant Proc. 2006 Jul-Aug;38(6):1731-2. doi: 10.1016/j.transproceed.2006.05.016.
5
Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
Inflamm Bowel Dis. 2006 Jun;12(6):524-34. doi: 10.1097/00054725-200606000-00013.
6
Serial transverse enteroplasty enhances intestinal function in a model of short bowel syndrome.
Ann Surg. 2006 Feb;243(2):223-8. doi: 10.1097/01.sla.0000197704.76166.07.
7
Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model.
Bone Marrow Transplant. 2005 Nov;36(10):907-15. doi: 10.1038/sj.bmt.1705157.
8
Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.
J Surg Res. 2005 Aug;127(2):177-82. doi: 10.1016/j.jss.2005.04.004.
9
Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome.
J Pediatr. 2005 Apr;146(4):542-7. doi: 10.1016/j.jpeds.2004.12.027.
10
Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.
Cancer. 2005 Jan 1;103(1):191-9. doi: 10.1002/cncr.20733.
Zotero 插件